TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) President and CEO Theuer Charles purchased 50,000 shares of the company stock in a transaction that occurred on August 9, 2019.
The shares were purchased at an average price of $ 0.45, for a total transaction of $ 22.50 thousand.
Following the completion of the transaction, the President and CEO now owns 173.57 thousand shares in the company, valued at approximately 78.10 thousand.
The transaction was disclosed in a filing with the SEC, which is available through SEC Filing Link.
According to the previous trading day, closing price of TCON was $ 0.45, representing a 11.11 % increase from the 52 week low of $ 0.40 and a 422.22 % decrease over the 52 week high of $ 2.35.